We've found
8,147
archived clinical trials in
Asthma
We've found
8,147
archived clinical trials in
Asthma
An 8-week Dose Ranging Study of CHF 718 pMDI in Asthmatic Subjects
Updated: 12/31/1969
An 8-week, Multicenter, Randomized, Double-blind, Placebo and Active-controlled, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of 3 Doses of CHF 718 pMDI (HFA Beclomethasone Dipropionate Via Pressured Metered Dose Inhaler) in Asthmatic Subjects.
Status: Enrolling
Updated: 12/31/1969
An 8-week Dose Ranging Study of CHF 718 pMDI in Asthmatic Subjects
Updated: 12/31/1969
An 8-week, Multicenter, Randomized, Double-blind, Placebo and Active-controlled, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of 3 Doses of CHF 718 pMDI (HFA Beclomethasone Dipropionate Via Pressured Metered Dose Inhaler) in Asthmatic Subjects.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
An 8-week Dose Ranging Study of CHF 718 pMDI in Asthmatic Subjects
Updated: 12/31/1969
An 8-week, Multicenter, Randomized, Double-blind, Placebo and Active-controlled, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of 3 Doses of CHF 718 pMDI (HFA Beclomethasone Dipropionate Via Pressured Metered Dose Inhaler) in Asthmatic Subjects.
Status: Enrolling
Updated: 12/31/1969
An 8-week Dose Ranging Study of CHF 718 pMDI in Asthmatic Subjects
Updated: 12/31/1969
An 8-week, Multicenter, Randomized, Double-blind, Placebo and Active-controlled, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of 3 Doses of CHF 718 pMDI (HFA Beclomethasone Dipropionate Via Pressured Metered Dose Inhaler) in Asthmatic Subjects.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
An 8-week Dose Ranging Study of CHF 718 pMDI in Asthmatic Subjects
Updated: 12/31/1969
An 8-week, Multicenter, Randomized, Double-blind, Placebo and Active-controlled, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of 3 Doses of CHF 718 pMDI (HFA Beclomethasone Dipropionate Via Pressured Metered Dose Inhaler) in Asthmatic Subjects.
Status: Enrolling
Updated: 12/31/1969
An 8-week Dose Ranging Study of CHF 718 pMDI in Asthmatic Subjects
Updated: 12/31/1969
An 8-week, Multicenter, Randomized, Double-blind, Placebo and Active-controlled, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of 3 Doses of CHF 718 pMDI (HFA Beclomethasone Dipropionate Via Pressured Metered Dose Inhaler) in Asthmatic Subjects.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
An 8-week Dose Ranging Study of CHF 718 pMDI in Asthmatic Subjects
Updated: 12/31/1969
An 8-week, Multicenter, Randomized, Double-blind, Placebo and Active-controlled, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of 3 Doses of CHF 718 pMDI (HFA Beclomethasone Dipropionate Via Pressured Metered Dose Inhaler) in Asthmatic Subjects.
Status: Enrolling
Updated: 12/31/1969
An 8-week Dose Ranging Study of CHF 718 pMDI in Asthmatic Subjects
Updated: 12/31/1969
An 8-week, Multicenter, Randomized, Double-blind, Placebo and Active-controlled, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of 3 Doses of CHF 718 pMDI (HFA Beclomethasone Dipropionate Via Pressured Metered Dose Inhaler) in Asthmatic Subjects.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
An 8-week Dose Ranging Study of CHF 718 pMDI in Asthmatic Subjects
Updated: 12/31/1969
An 8-week, Multicenter, Randomized, Double-blind, Placebo and Active-controlled, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of 3 Doses of CHF 718 pMDI (HFA Beclomethasone Dipropionate Via Pressured Metered Dose Inhaler) in Asthmatic Subjects.
Status: Enrolling
Updated: 12/31/1969
An 8-week Dose Ranging Study of CHF 718 pMDI in Asthmatic Subjects
Updated: 12/31/1969
An 8-week, Multicenter, Randomized, Double-blind, Placebo and Active-controlled, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of 3 Doses of CHF 718 pMDI (HFA Beclomethasone Dipropionate Via Pressured Metered Dose Inhaler) in Asthmatic Subjects.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
An 8-week Dose Ranging Study of CHF 718 pMDI in Asthmatic Subjects
Updated: 12/31/1969
An 8-week, Multicenter, Randomized, Double-blind, Placebo and Active-controlled, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of 3 Doses of CHF 718 pMDI (HFA Beclomethasone Dipropionate Via Pressured Metered Dose Inhaler) in Asthmatic Subjects.
Status: Enrolling
Updated: 12/31/1969
An 8-week Dose Ranging Study of CHF 718 pMDI in Asthmatic Subjects
Updated: 12/31/1969
An 8-week, Multicenter, Randomized, Double-blind, Placebo and Active-controlled, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of 3 Doses of CHF 718 pMDI (HFA Beclomethasone Dipropionate Via Pressured Metered Dose Inhaler) in Asthmatic Subjects.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
An 8-week Dose Ranging Study of CHF 718 pMDI in Asthmatic Subjects
Updated: 12/31/1969
An 8-week, Multicenter, Randomized, Double-blind, Placebo and Active-controlled, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of 3 Doses of CHF 718 pMDI (HFA Beclomethasone Dipropionate Via Pressured Metered Dose Inhaler) in Asthmatic Subjects.
Status: Enrolling
Updated: 12/31/1969
An 8-week Dose Ranging Study of CHF 718 pMDI in Asthmatic Subjects
Updated: 12/31/1969
An 8-week, Multicenter, Randomized, Double-blind, Placebo and Active-controlled, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of 3 Doses of CHF 718 pMDI (HFA Beclomethasone Dipropionate Via Pressured Metered Dose Inhaler) in Asthmatic Subjects.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
An 8-week Dose Ranging Study of CHF 718 pMDI in Asthmatic Subjects
Updated: 12/31/1969
An 8-week, Multicenter, Randomized, Double-blind, Placebo and Active-controlled, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of 3 Doses of CHF 718 pMDI (HFA Beclomethasone Dipropionate Via Pressured Metered Dose Inhaler) in Asthmatic Subjects.
Status: Enrolling
Updated: 12/31/1969
An 8-week Dose Ranging Study of CHF 718 pMDI in Asthmatic Subjects
Updated: 12/31/1969
An 8-week, Multicenter, Randomized, Double-blind, Placebo and Active-controlled, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of 3 Doses of CHF 718 pMDI (HFA Beclomethasone Dipropionate Via Pressured Metered Dose Inhaler) in Asthmatic Subjects.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
An 8-week Dose Ranging Study of CHF 718 pMDI in Asthmatic Subjects
Updated: 12/31/1969
An 8-week, Multicenter, Randomized, Double-blind, Placebo and Active-controlled, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of 3 Doses of CHF 718 pMDI (HFA Beclomethasone Dipropionate Via Pressured Metered Dose Inhaler) in Asthmatic Subjects.
Status: Enrolling
Updated: 12/31/1969
An 8-week Dose Ranging Study of CHF 718 pMDI in Asthmatic Subjects
Updated: 12/31/1969
An 8-week, Multicenter, Randomized, Double-blind, Placebo and Active-controlled, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of 3 Doses of CHF 718 pMDI (HFA Beclomethasone Dipropionate Via Pressured Metered Dose Inhaler) in Asthmatic Subjects.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
An 8-week Dose Ranging Study of CHF 718 pMDI in Asthmatic Subjects
Updated: 12/31/1969
An 8-week, Multicenter, Randomized, Double-blind, Placebo and Active-controlled, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of 3 Doses of CHF 718 pMDI (HFA Beclomethasone Dipropionate Via Pressured Metered Dose Inhaler) in Asthmatic Subjects.
Status: Enrolling
Updated: 12/31/1969
An 8-week Dose Ranging Study of CHF 718 pMDI in Asthmatic Subjects
Updated: 12/31/1969
An 8-week, Multicenter, Randomized, Double-blind, Placebo and Active-controlled, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of 3 Doses of CHF 718 pMDI (HFA Beclomethasone Dipropionate Via Pressured Metered Dose Inhaler) in Asthmatic Subjects.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
An 8-week Dose Ranging Study of CHF 718 pMDI in Asthmatic Subjects
Updated: 12/31/1969
An 8-week, Multicenter, Randomized, Double-blind, Placebo and Active-controlled, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of 3 Doses of CHF 718 pMDI (HFA Beclomethasone Dipropionate Via Pressured Metered Dose Inhaler) in Asthmatic Subjects.
Status: Enrolling
Updated: 12/31/1969
An 8-week Dose Ranging Study of CHF 718 pMDI in Asthmatic Subjects
Updated: 12/31/1969
An 8-week, Multicenter, Randomized, Double-blind, Placebo and Active-controlled, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of 3 Doses of CHF 718 pMDI (HFA Beclomethasone Dipropionate Via Pressured Metered Dose Inhaler) in Asthmatic Subjects.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
An 8-week Dose Ranging Study of CHF 718 pMDI in Asthmatic Subjects
Updated: 12/31/1969
An 8-week, Multicenter, Randomized, Double-blind, Placebo and Active-controlled, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of 3 Doses of CHF 718 pMDI (HFA Beclomethasone Dipropionate Via Pressured Metered Dose Inhaler) in Asthmatic Subjects.
Status: Enrolling
Updated: 12/31/1969
An 8-week Dose Ranging Study of CHF 718 pMDI in Asthmatic Subjects
Updated: 12/31/1969
An 8-week, Multicenter, Randomized, Double-blind, Placebo and Active-controlled, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of 3 Doses of CHF 718 pMDI (HFA Beclomethasone Dipropionate Via Pressured Metered Dose Inhaler) in Asthmatic Subjects.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
An 8-week Dose Ranging Study of CHF 718 pMDI in Asthmatic Subjects
Updated: 12/31/1969
An 8-week, Multicenter, Randomized, Double-blind, Placebo and Active-controlled, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of 3 Doses of CHF 718 pMDI (HFA Beclomethasone Dipropionate Via Pressured Metered Dose Inhaler) in Asthmatic Subjects.
Status: Enrolling
Updated: 12/31/1969
An 8-week Dose Ranging Study of CHF 718 pMDI in Asthmatic Subjects
Updated: 12/31/1969
An 8-week, Multicenter, Randomized, Double-blind, Placebo and Active-controlled, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of 3 Doses of CHF 718 pMDI (HFA Beclomethasone Dipropionate Via Pressured Metered Dose Inhaler) in Asthmatic Subjects.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
An 8-week Dose Ranging Study of CHF 718 pMDI in Asthmatic Subjects
Updated: 12/31/1969
An 8-week, Multicenter, Randomized, Double-blind, Placebo and Active-controlled, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of 3 Doses of CHF 718 pMDI (HFA Beclomethasone Dipropionate Via Pressured Metered Dose Inhaler) in Asthmatic Subjects.
Status: Enrolling
Updated: 12/31/1969
An 8-week Dose Ranging Study of CHF 718 pMDI in Asthmatic Subjects
Updated: 12/31/1969
An 8-week, Multicenter, Randomized, Double-blind, Placebo and Active-controlled, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of 3 Doses of CHF 718 pMDI (HFA Beclomethasone Dipropionate Via Pressured Metered Dose Inhaler) in Asthmatic Subjects.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
An 8-week Dose Ranging Study of CHF 718 pMDI in Asthmatic Subjects
Updated: 12/31/1969
An 8-week, Multicenter, Randomized, Double-blind, Placebo and Active-controlled, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of 3 Doses of CHF 718 pMDI (HFA Beclomethasone Dipropionate Via Pressured Metered Dose Inhaler) in Asthmatic Subjects.
Status: Enrolling
Updated: 12/31/1969
An 8-week Dose Ranging Study of CHF 718 pMDI in Asthmatic Subjects
Updated: 12/31/1969
An 8-week, Multicenter, Randomized, Double-blind, Placebo and Active-controlled, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of 3 Doses of CHF 718 pMDI (HFA Beclomethasone Dipropionate Via Pressured Metered Dose Inhaler) in Asthmatic Subjects.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
An 8-week Dose Ranging Study of CHF 718 pMDI in Asthmatic Subjects
Updated: 12/31/1969
An 8-week, Multicenter, Randomized, Double-blind, Placebo and Active-controlled, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of 3 Doses of CHF 718 pMDI (HFA Beclomethasone Dipropionate Via Pressured Metered Dose Inhaler) in Asthmatic Subjects.
Status: Enrolling
Updated: 12/31/1969
An 8-week Dose Ranging Study of CHF 718 pMDI in Asthmatic Subjects
Updated: 12/31/1969
An 8-week, Multicenter, Randomized, Double-blind, Placebo and Active-controlled, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of 3 Doses of CHF 718 pMDI (HFA Beclomethasone Dipropionate Via Pressured Metered Dose Inhaler) in Asthmatic Subjects.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
An 8-week Dose Ranging Study of CHF 718 pMDI in Asthmatic Subjects
Updated: 12/31/1969
An 8-week, Multicenter, Randomized, Double-blind, Placebo and Active-controlled, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of 3 Doses of CHF 718 pMDI (HFA Beclomethasone Dipropionate Via Pressured Metered Dose Inhaler) in Asthmatic Subjects.
Status: Enrolling
Updated: 12/31/1969
An 8-week Dose Ranging Study of CHF 718 pMDI in Asthmatic Subjects
Updated: 12/31/1969
An 8-week, Multicenter, Randomized, Double-blind, Placebo and Active-controlled, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of 3 Doses of CHF 718 pMDI (HFA Beclomethasone Dipropionate Via Pressured Metered Dose Inhaler) in Asthmatic Subjects.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
An 8-week Dose Ranging Study of CHF 718 pMDI in Asthmatic Subjects
Updated: 12/31/1969
An 8-week, Multicenter, Randomized, Double-blind, Placebo and Active-controlled, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of 3 Doses of CHF 718 pMDI (HFA Beclomethasone Dipropionate Via Pressured Metered Dose Inhaler) in Asthmatic Subjects.
Status: Enrolling
Updated: 12/31/1969
An 8-week Dose Ranging Study of CHF 718 pMDI in Asthmatic Subjects
Updated: 12/31/1969
An 8-week, Multicenter, Randomized, Double-blind, Placebo and Active-controlled, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of 3 Doses of CHF 718 pMDI (HFA Beclomethasone Dipropionate Via Pressured Metered Dose Inhaler) in Asthmatic Subjects.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
An 8-week Dose Ranging Study of CHF 718 pMDI in Asthmatic Subjects
Updated: 12/31/1969
An 8-week, Multicenter, Randomized, Double-blind, Placebo and Active-controlled, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of 3 Doses of CHF 718 pMDI (HFA Beclomethasone Dipropionate Via Pressured Metered Dose Inhaler) in Asthmatic Subjects.
Status: Enrolling
Updated: 12/31/1969
An 8-week Dose Ranging Study of CHF 718 pMDI in Asthmatic Subjects
Updated: 12/31/1969
An 8-week, Multicenter, Randomized, Double-blind, Placebo and Active-controlled, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of 3 Doses of CHF 718 pMDI (HFA Beclomethasone Dipropionate Via Pressured Metered Dose Inhaler) in Asthmatic Subjects.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
An 8-week Dose Ranging Study of CHF 718 pMDI in Asthmatic Subjects
Updated: 12/31/1969
An 8-week, Multicenter, Randomized, Double-blind, Placebo and Active-controlled, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of 3 Doses of CHF 718 pMDI (HFA Beclomethasone Dipropionate Via Pressured Metered Dose Inhaler) in Asthmatic Subjects.
Status: Enrolling
Updated: 12/31/1969
An 8-week Dose Ranging Study of CHF 718 pMDI in Asthmatic Subjects
Updated: 12/31/1969
An 8-week, Multicenter, Randomized, Double-blind, Placebo and Active-controlled, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of 3 Doses of CHF 718 pMDI (HFA Beclomethasone Dipropionate Via Pressured Metered Dose Inhaler) in Asthmatic Subjects.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
An 8-week Dose Ranging Study of CHF 718 pMDI in Asthmatic Subjects
Updated: 12/31/1969
An 8-week, Multicenter, Randomized, Double-blind, Placebo and Active-controlled, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of 3 Doses of CHF 718 pMDI (HFA Beclomethasone Dipropionate Via Pressured Metered Dose Inhaler) in Asthmatic Subjects.
Status: Enrolling
Updated: 12/31/1969
An 8-week Dose Ranging Study of CHF 718 pMDI in Asthmatic Subjects
Updated: 12/31/1969
An 8-week, Multicenter, Randomized, Double-blind, Placebo and Active-controlled, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of 3 Doses of CHF 718 pMDI (HFA Beclomethasone Dipropionate Via Pressured Metered Dose Inhaler) in Asthmatic Subjects.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
An 8-week Dose Ranging Study of CHF 718 pMDI in Asthmatic Subjects
Updated: 12/31/1969
An 8-week, Multicenter, Randomized, Double-blind, Placebo and Active-controlled, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of 3 Doses of CHF 718 pMDI (HFA Beclomethasone Dipropionate Via Pressured Metered Dose Inhaler) in Asthmatic Subjects.
Status: Enrolling
Updated: 12/31/1969
An 8-week Dose Ranging Study of CHF 718 pMDI in Asthmatic Subjects
Updated: 12/31/1969
An 8-week, Multicenter, Randomized, Double-blind, Placebo and Active-controlled, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of 3 Doses of CHF 718 pMDI (HFA Beclomethasone Dipropionate Via Pressured Metered Dose Inhaler) in Asthmatic Subjects.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
An 8-week Dose Ranging Study of CHF 718 pMDI in Asthmatic Subjects
Updated: 12/31/1969
An 8-week, Multicenter, Randomized, Double-blind, Placebo and Active-controlled, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of 3 Doses of CHF 718 pMDI (HFA Beclomethasone Dipropionate Via Pressured Metered Dose Inhaler) in Asthmatic Subjects.
Status: Enrolling
Updated: 12/31/1969
An 8-week Dose Ranging Study of CHF 718 pMDI in Asthmatic Subjects
Updated: 12/31/1969
An 8-week, Multicenter, Randomized, Double-blind, Placebo and Active-controlled, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of 3 Doses of CHF 718 pMDI (HFA Beclomethasone Dipropionate Via Pressured Metered Dose Inhaler) in Asthmatic Subjects.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
An 8-week Dose Ranging Study of CHF 718 pMDI in Asthmatic Subjects
Updated: 12/31/1969
An 8-week, Multicenter, Randomized, Double-blind, Placebo and Active-controlled, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of 3 Doses of CHF 718 pMDI (HFA Beclomethasone Dipropionate Via Pressured Metered Dose Inhaler) in Asthmatic Subjects.
Status: Enrolling
Updated: 12/31/1969
An 8-week Dose Ranging Study of CHF 718 pMDI in Asthmatic Subjects
Updated: 12/31/1969
An 8-week, Multicenter, Randomized, Double-blind, Placebo and Active-controlled, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of 3 Doses of CHF 718 pMDI (HFA Beclomethasone Dipropionate Via Pressured Metered Dose Inhaler) in Asthmatic Subjects.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
An 8-week Dose Ranging Study of CHF 718 pMDI in Asthmatic Subjects
Updated: 12/31/1969
An 8-week, Multicenter, Randomized, Double-blind, Placebo and Active-controlled, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of 3 Doses of CHF 718 pMDI (HFA Beclomethasone Dipropionate Via Pressured Metered Dose Inhaler) in Asthmatic Subjects.
Status: Enrolling
Updated: 12/31/1969
An 8-week Dose Ranging Study of CHF 718 pMDI in Asthmatic Subjects
Updated: 12/31/1969
An 8-week, Multicenter, Randomized, Double-blind, Placebo and Active-controlled, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of 3 Doses of CHF 718 pMDI (HFA Beclomethasone Dipropionate Via Pressured Metered Dose Inhaler) in Asthmatic Subjects.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
An 8-week Dose Ranging Study of CHF 718 pMDI in Asthmatic Subjects
Updated: 12/31/1969
An 8-week, Multicenter, Randomized, Double-blind, Placebo and Active-controlled, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of 3 Doses of CHF 718 pMDI (HFA Beclomethasone Dipropionate Via Pressured Metered Dose Inhaler) in Asthmatic Subjects.
Status: Enrolling
Updated: 12/31/1969
An 8-week Dose Ranging Study of CHF 718 pMDI in Asthmatic Subjects
Updated: 12/31/1969
An 8-week, Multicenter, Randomized, Double-blind, Placebo and Active-controlled, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of 3 Doses of CHF 718 pMDI (HFA Beclomethasone Dipropionate Via Pressured Metered Dose Inhaler) in Asthmatic Subjects.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
An 8-week Dose Ranging Study of CHF 718 pMDI in Asthmatic Subjects
Updated: 12/31/1969
An 8-week, Multicenter, Randomized, Double-blind, Placebo and Active-controlled, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of 3 Doses of CHF 718 pMDI (HFA Beclomethasone Dipropionate Via Pressured Metered Dose Inhaler) in Asthmatic Subjects.
Status: Enrolling
Updated: 12/31/1969
An 8-week Dose Ranging Study of CHF 718 pMDI in Asthmatic Subjects
Updated: 12/31/1969
An 8-week, Multicenter, Randomized, Double-blind, Placebo and Active-controlled, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of 3 Doses of CHF 718 pMDI (HFA Beclomethasone Dipropionate Via Pressured Metered Dose Inhaler) in Asthmatic Subjects.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
An 8-week Dose Ranging Study of CHF 718 pMDI in Asthmatic Subjects
Updated: 12/31/1969
An 8-week, Multicenter, Randomized, Double-blind, Placebo and Active-controlled, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of 3 Doses of CHF 718 pMDI (HFA Beclomethasone Dipropionate Via Pressured Metered Dose Inhaler) in Asthmatic Subjects.
Status: Enrolling
Updated: 12/31/1969
An 8-week Dose Ranging Study of CHF 718 pMDI in Asthmatic Subjects
Updated: 12/31/1969
An 8-week, Multicenter, Randomized, Double-blind, Placebo and Active-controlled, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of 3 Doses of CHF 718 pMDI (HFA Beclomethasone Dipropionate Via Pressured Metered Dose Inhaler) in Asthmatic Subjects.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
An 8-week Dose Ranging Study of CHF 718 pMDI in Asthmatic Subjects
Updated: 12/31/1969
An 8-week, Multicenter, Randomized, Double-blind, Placebo and Active-controlled, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of 3 Doses of CHF 718 pMDI (HFA Beclomethasone Dipropionate Via Pressured Metered Dose Inhaler) in Asthmatic Subjects.
Status: Enrolling
Updated: 12/31/1969
An 8-week Dose Ranging Study of CHF 718 pMDI in Asthmatic Subjects
Updated: 12/31/1969
An 8-week, Multicenter, Randomized, Double-blind, Placebo and Active-controlled, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of 3 Doses of CHF 718 pMDI (HFA Beclomethasone Dipropionate Via Pressured Metered Dose Inhaler) in Asthmatic Subjects.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
An 8-week Dose Ranging Study of CHF 718 pMDI in Asthmatic Subjects
Updated: 12/31/1969
An 8-week, Multicenter, Randomized, Double-blind, Placebo and Active-controlled, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of 3 Doses of CHF 718 pMDI (HFA Beclomethasone Dipropionate Via Pressured Metered Dose Inhaler) in Asthmatic Subjects.
Status: Enrolling
Updated: 12/31/1969
An 8-week Dose Ranging Study of CHF 718 pMDI in Asthmatic Subjects
Updated: 12/31/1969
An 8-week, Multicenter, Randomized, Double-blind, Placebo and Active-controlled, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of 3 Doses of CHF 718 pMDI (HFA Beclomethasone Dipropionate Via Pressured Metered Dose Inhaler) in Asthmatic Subjects.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
An 8-week Dose Ranging Study of CHF 718 pMDI in Asthmatic Subjects
Updated: 12/31/1969
An 8-week, Multicenter, Randomized, Double-blind, Placebo and Active-controlled, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of 3 Doses of CHF 718 pMDI (HFA Beclomethasone Dipropionate Via Pressured Metered Dose Inhaler) in Asthmatic Subjects.
Status: Enrolling
Updated: 12/31/1969
An 8-week Dose Ranging Study of CHF 718 pMDI in Asthmatic Subjects
Updated: 12/31/1969
An 8-week, Multicenter, Randomized, Double-blind, Placebo and Active-controlled, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of 3 Doses of CHF 718 pMDI (HFA Beclomethasone Dipropionate Via Pressured Metered Dose Inhaler) in Asthmatic Subjects.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
An 8-week Dose Ranging Study of CHF 718 pMDI in Asthmatic Subjects
Updated: 12/31/1969
An 8-week, Multicenter, Randomized, Double-blind, Placebo and Active-controlled, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of 3 Doses of CHF 718 pMDI (HFA Beclomethasone Dipropionate Via Pressured Metered Dose Inhaler) in Asthmatic Subjects.
Status: Enrolling
Updated: 12/31/1969
An 8-week Dose Ranging Study of CHF 718 pMDI in Asthmatic Subjects
Updated: 12/31/1969
An 8-week, Multicenter, Randomized, Double-blind, Placebo and Active-controlled, Parallel Group, Dose-ranging Study to Evaluate the Efficacy and Safety of 3 Doses of CHF 718 pMDI (HFA Beclomethasone Dipropionate Via Pressured Metered Dose Inhaler) in Asthmatic Subjects.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
BREATHE-Easy Trial
Updated: 12/31/1969
Western Versus Prudent Diet Feeding Study in Adult Women With Asthma
Status: Enrolling
Updated: 12/31/1969
BREATHE-Easy Trial
Updated: 12/31/1969
Western Versus Prudent Diet Feeding Study in Adult Women With Asthma
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Dose Ranging Study of CHF 1531 in Asthmatic Subjects
Updated: 12/31/1969
A Randomized, Double-blind, Placebo and Active-controlled, Incomplete Block Cross-over, Dose Ranging Study to Evaluate the Efficacy and Safety of 4 Doses of CHF 1531 pMDI (Formoterol Fumarate) in Asthmatic Subjects
Status: Enrolling
Updated: 12/31/1969
A Dose Ranging Study of CHF 1531 in Asthmatic Subjects
Updated: 12/31/1969
A Randomized, Double-blind, Placebo and Active-controlled, Incomplete Block Cross-over, Dose Ranging Study to Evaluate the Efficacy and Safety of 4 Doses of CHF 1531 pMDI (Formoterol Fumarate) in Asthmatic Subjects
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Dose Ranging Study of CHF 1531 in Asthmatic Subjects
Updated: 12/31/1969
A Randomized, Double-blind, Placebo and Active-controlled, Incomplete Block Cross-over, Dose Ranging Study to Evaluate the Efficacy and Safety of 4 Doses of CHF 1531 pMDI (Formoterol Fumarate) in Asthmatic Subjects
Status: Enrolling
Updated: 12/31/1969
A Dose Ranging Study of CHF 1531 in Asthmatic Subjects
Updated: 12/31/1969
A Randomized, Double-blind, Placebo and Active-controlled, Incomplete Block Cross-over, Dose Ranging Study to Evaluate the Efficacy and Safety of 4 Doses of CHF 1531 pMDI (Formoterol Fumarate) in Asthmatic Subjects
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Dose Ranging Study of CHF 1531 in Asthmatic Subjects
Updated: 12/31/1969
A Randomized, Double-blind, Placebo and Active-controlled, Incomplete Block Cross-over, Dose Ranging Study to Evaluate the Efficacy and Safety of 4 Doses of CHF 1531 pMDI (Formoterol Fumarate) in Asthmatic Subjects
Status: Enrolling
Updated: 12/31/1969
A Dose Ranging Study of CHF 1531 in Asthmatic Subjects
Updated: 12/31/1969
A Randomized, Double-blind, Placebo and Active-controlled, Incomplete Block Cross-over, Dose Ranging Study to Evaluate the Efficacy and Safety of 4 Doses of CHF 1531 pMDI (Formoterol Fumarate) in Asthmatic Subjects
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Dose Ranging Study of CHF 1531 in Asthmatic Subjects
Updated: 12/31/1969
A Randomized, Double-blind, Placebo and Active-controlled, Incomplete Block Cross-over, Dose Ranging Study to Evaluate the Efficacy and Safety of 4 Doses of CHF 1531 pMDI (Formoterol Fumarate) in Asthmatic Subjects
Status: Enrolling
Updated: 12/31/1969
A Dose Ranging Study of CHF 1531 in Asthmatic Subjects
Updated: 12/31/1969
A Randomized, Double-blind, Placebo and Active-controlled, Incomplete Block Cross-over, Dose Ranging Study to Evaluate the Efficacy and Safety of 4 Doses of CHF 1531 pMDI (Formoterol Fumarate) in Asthmatic Subjects
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Dose Ranging Study of CHF 1531 in Asthmatic Subjects
Updated: 12/31/1969
A Randomized, Double-blind, Placebo and Active-controlled, Incomplete Block Cross-over, Dose Ranging Study to Evaluate the Efficacy and Safety of 4 Doses of CHF 1531 pMDI (Formoterol Fumarate) in Asthmatic Subjects
Status: Enrolling
Updated: 12/31/1969
A Dose Ranging Study of CHF 1531 in Asthmatic Subjects
Updated: 12/31/1969
A Randomized, Double-blind, Placebo and Active-controlled, Incomplete Block Cross-over, Dose Ranging Study to Evaluate the Efficacy and Safety of 4 Doses of CHF 1531 pMDI (Formoterol Fumarate) in Asthmatic Subjects
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Dose Ranging Study of CHF 1531 in Asthmatic Subjects
Updated: 12/31/1969
A Randomized, Double-blind, Placebo and Active-controlled, Incomplete Block Cross-over, Dose Ranging Study to Evaluate the Efficacy and Safety of 4 Doses of CHF 1531 pMDI (Formoterol Fumarate) in Asthmatic Subjects
Status: Enrolling
Updated: 12/31/1969
A Dose Ranging Study of CHF 1531 in Asthmatic Subjects
Updated: 12/31/1969
A Randomized, Double-blind, Placebo and Active-controlled, Incomplete Block Cross-over, Dose Ranging Study to Evaluate the Efficacy and Safety of 4 Doses of CHF 1531 pMDI (Formoterol Fumarate) in Asthmatic Subjects
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Dose Ranging Study of CHF 1531 in Asthmatic Subjects
Updated: 12/31/1969
A Randomized, Double-blind, Placebo and Active-controlled, Incomplete Block Cross-over, Dose Ranging Study to Evaluate the Efficacy and Safety of 4 Doses of CHF 1531 pMDI (Formoterol Fumarate) in Asthmatic Subjects
Status: Enrolling
Updated: 12/31/1969
A Dose Ranging Study of CHF 1531 in Asthmatic Subjects
Updated: 12/31/1969
A Randomized, Double-blind, Placebo and Active-controlled, Incomplete Block Cross-over, Dose Ranging Study to Evaluate the Efficacy and Safety of 4 Doses of CHF 1531 pMDI (Formoterol Fumarate) in Asthmatic Subjects
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Dose Ranging Study of CHF 1531 in Asthmatic Subjects
Updated: 12/31/1969
A Randomized, Double-blind, Placebo and Active-controlled, Incomplete Block Cross-over, Dose Ranging Study to Evaluate the Efficacy and Safety of 4 Doses of CHF 1531 pMDI (Formoterol Fumarate) in Asthmatic Subjects
Status: Enrolling
Updated: 12/31/1969
A Dose Ranging Study of CHF 1531 in Asthmatic Subjects
Updated: 12/31/1969
A Randomized, Double-blind, Placebo and Active-controlled, Incomplete Block Cross-over, Dose Ranging Study to Evaluate the Efficacy and Safety of 4 Doses of CHF 1531 pMDI (Formoterol Fumarate) in Asthmatic Subjects
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Dose Ranging Study of CHF 1531 in Asthmatic Subjects
Updated: 12/31/1969
A Randomized, Double-blind, Placebo and Active-controlled, Incomplete Block Cross-over, Dose Ranging Study to Evaluate the Efficacy and Safety of 4 Doses of CHF 1531 pMDI (Formoterol Fumarate) in Asthmatic Subjects
Status: Enrolling
Updated: 12/31/1969
A Dose Ranging Study of CHF 1531 in Asthmatic Subjects
Updated: 12/31/1969
A Randomized, Double-blind, Placebo and Active-controlled, Incomplete Block Cross-over, Dose Ranging Study to Evaluate the Efficacy and Safety of 4 Doses of CHF 1531 pMDI (Formoterol Fumarate) in Asthmatic Subjects
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Dose Ranging Study of CHF 1531 in Asthmatic Subjects
Updated: 12/31/1969
A Randomized, Double-blind, Placebo and Active-controlled, Incomplete Block Cross-over, Dose Ranging Study to Evaluate the Efficacy and Safety of 4 Doses of CHF 1531 pMDI (Formoterol Fumarate) in Asthmatic Subjects
Status: Enrolling
Updated: 12/31/1969
A Dose Ranging Study of CHF 1531 in Asthmatic Subjects
Updated: 12/31/1969
A Randomized, Double-blind, Placebo and Active-controlled, Incomplete Block Cross-over, Dose Ranging Study to Evaluate the Efficacy and Safety of 4 Doses of CHF 1531 pMDI (Formoterol Fumarate) in Asthmatic Subjects
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study to Compare PT007 to Placebo MDI and Open-Label Proventil® HFA in Adult and Adolescent Subjects With Asthma
Updated: 12/31/1969
A Randomized, Double-blind, Single Dose, Placebo-controlled, 5-Period, 5-Treatment, Crossover, Multi-center, Dose-ranging Study to Compare PT007 to Placebo MDI and Open-Label Proventil® HFA in Adult and Adolescent Subjects With Mild to Moderate Asthma (ANTORA)
Status: Enrolling
Updated: 12/31/1969
Study to Compare PT007 to Placebo MDI and Open-Label Proventil® HFA in Adult and Adolescent Subjects With Asthma
Updated: 12/31/1969
A Randomized, Double-blind, Single Dose, Placebo-controlled, 5-Period, 5-Treatment, Crossover, Multi-center, Dose-ranging Study to Compare PT007 to Placebo MDI and Open-Label Proventil® HFA in Adult and Adolescent Subjects With Mild to Moderate Asthma (ANTORA)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study to Compare PT007 to Placebo MDI and Open-Label Proventil® HFA in Adult and Adolescent Subjects With Asthma
Updated: 12/31/1969
A Randomized, Double-blind, Single Dose, Placebo-controlled, 5-Period, 5-Treatment, Crossover, Multi-center, Dose-ranging Study to Compare PT007 to Placebo MDI and Open-Label Proventil® HFA in Adult and Adolescent Subjects With Mild to Moderate Asthma (ANTORA)
Status: Enrolling
Updated: 12/31/1969
Study to Compare PT007 to Placebo MDI and Open-Label Proventil® HFA in Adult and Adolescent Subjects With Asthma
Updated: 12/31/1969
A Randomized, Double-blind, Single Dose, Placebo-controlled, 5-Period, 5-Treatment, Crossover, Multi-center, Dose-ranging Study to Compare PT007 to Placebo MDI and Open-Label Proventil® HFA in Adult and Adolescent Subjects With Mild to Moderate Asthma (ANTORA)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study to Compare PT007 to Placebo MDI and Open-Label Proventil® HFA in Adult and Adolescent Subjects With Asthma
Updated: 12/31/1969
A Randomized, Double-blind, Single Dose, Placebo-controlled, 5-Period, 5-Treatment, Crossover, Multi-center, Dose-ranging Study to Compare PT007 to Placebo MDI and Open-Label Proventil® HFA in Adult and Adolescent Subjects With Mild to Moderate Asthma (ANTORA)
Status: Enrolling
Updated: 12/31/1969
Study to Compare PT007 to Placebo MDI and Open-Label Proventil® HFA in Adult and Adolescent Subjects With Asthma
Updated: 12/31/1969
A Randomized, Double-blind, Single Dose, Placebo-controlled, 5-Period, 5-Treatment, Crossover, Multi-center, Dose-ranging Study to Compare PT007 to Placebo MDI and Open-Label Proventil® HFA in Adult and Adolescent Subjects With Mild to Moderate Asthma (ANTORA)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study to Compare PT007 to Placebo MDI and Open-Label Proventil® HFA in Adult and Adolescent Subjects With Asthma
Updated: 12/31/1969
A Randomized, Double-blind, Single Dose, Placebo-controlled, 5-Period, 5-Treatment, Crossover, Multi-center, Dose-ranging Study to Compare PT007 to Placebo MDI and Open-Label Proventil® HFA in Adult and Adolescent Subjects With Mild to Moderate Asthma (ANTORA)
Status: Enrolling
Updated: 12/31/1969
Study to Compare PT007 to Placebo MDI and Open-Label Proventil® HFA in Adult and Adolescent Subjects With Asthma
Updated: 12/31/1969
A Randomized, Double-blind, Single Dose, Placebo-controlled, 5-Period, 5-Treatment, Crossover, Multi-center, Dose-ranging Study to Compare PT007 to Placebo MDI and Open-Label Proventil® HFA in Adult and Adolescent Subjects With Mild to Moderate Asthma (ANTORA)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study to Compare PT007 to Placebo MDI and Open-Label Proventil® HFA in Adult and Adolescent Subjects With Asthma
Updated: 12/31/1969
A Randomized, Double-blind, Single Dose, Placebo-controlled, 5-Period, 5-Treatment, Crossover, Multi-center, Dose-ranging Study to Compare PT007 to Placebo MDI and Open-Label Proventil® HFA in Adult and Adolescent Subjects With Mild to Moderate Asthma (ANTORA)
Status: Enrolling
Updated: 12/31/1969
Study to Compare PT007 to Placebo MDI and Open-Label Proventil® HFA in Adult and Adolescent Subjects With Asthma
Updated: 12/31/1969
A Randomized, Double-blind, Single Dose, Placebo-controlled, 5-Period, 5-Treatment, Crossover, Multi-center, Dose-ranging Study to Compare PT007 to Placebo MDI and Open-Label Proventil® HFA in Adult and Adolescent Subjects With Mild to Moderate Asthma (ANTORA)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study to Compare PT007 to Placebo MDI and Open-Label Proventil® HFA in Adult and Adolescent Subjects With Asthma
Updated: 12/31/1969
A Randomized, Double-blind, Single Dose, Placebo-controlled, 5-Period, 5-Treatment, Crossover, Multi-center, Dose-ranging Study to Compare PT007 to Placebo MDI and Open-Label Proventil® HFA in Adult and Adolescent Subjects With Mild to Moderate Asthma (ANTORA)
Status: Enrolling
Updated: 12/31/1969
Study to Compare PT007 to Placebo MDI and Open-Label Proventil® HFA in Adult and Adolescent Subjects With Asthma
Updated: 12/31/1969
A Randomized, Double-blind, Single Dose, Placebo-controlled, 5-Period, 5-Treatment, Crossover, Multi-center, Dose-ranging Study to Compare PT007 to Placebo MDI and Open-Label Proventil® HFA in Adult and Adolescent Subjects With Mild to Moderate Asthma (ANTORA)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study to Compare PT007 to Placebo MDI and Open-Label Proventil® HFA in Adult and Adolescent Subjects With Asthma
Updated: 12/31/1969
A Randomized, Double-blind, Single Dose, Placebo-controlled, 5-Period, 5-Treatment, Crossover, Multi-center, Dose-ranging Study to Compare PT007 to Placebo MDI and Open-Label Proventil® HFA in Adult and Adolescent Subjects With Mild to Moderate Asthma (ANTORA)
Status: Enrolling
Updated: 12/31/1969
Study to Compare PT007 to Placebo MDI and Open-Label Proventil® HFA in Adult and Adolescent Subjects With Asthma
Updated: 12/31/1969
A Randomized, Double-blind, Single Dose, Placebo-controlled, 5-Period, 5-Treatment, Crossover, Multi-center, Dose-ranging Study to Compare PT007 to Placebo MDI and Open-Label Proventil® HFA in Adult and Adolescent Subjects With Mild to Moderate Asthma (ANTORA)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials